Method of use for murine leukaemia inhibitory factor-binding protein (mLBP)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 14, 2002
Grant Date -
N/A
app pub date -
Nov 10, 1994
filing date -
Jul 1, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a isolated leukaemia inhibitory factor (LIF)-binding protein (LBP) in soluble form and obtainable from a first mammalian species, said LBP capable of inhibiting the ability of LIF from a second mammalian species to induce differentiation of M1 myeloid leukaemic cells in vitro to a greater extent when compared to its ability to inhibit LIF from said first mammalian species.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully